Importantly, NSCLC cells expressing mutant EGFR underwent extensive apoptosis after treatment with pharmacological inhibitors of AKT (Ly294002) and STAT (AG490) signaling [33]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.